Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Abdominal Radiology (New York)|June 4, 2026
Comparison of [<sup>68</sup>Ga]Ga-FAPI PET/CT with CECT in the detection of peritoneal metastases from ovarian cancers and impact on clinical treatment decisionsYunuan Liu, Fenglian Jing, Xiaoshan Chen, et al.Chemistry & Biodiversity|January 1, 2024
Optimization of the synthesis of BET BD2 selective inhibitor XY153Run Zhu, Junhua Li, Ruibo Dong, et al.Elife|November 10, 2022
An automated feeding system for the African killifish reveals the impact of diet on lifespan and allows scalable assessment of associative learningAndrew McKay, Emma K Costa, Jingxun Chen, et al.Abdominal Radiology (New York)|June 27, 2024
Comparison of <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT in diagnosing ovarian cancerYunuan Liu, Jiangyang Pan, Fenglian Jing, et al.Abdominal Radiology (New York)|January 3, 2025
<sup>68</sup>Ga-DOTA-FAPI-04 and <sup>18</sup>F-FDG PET/CT: a head-to-head comparison for peritoneal carcinomatosis diagnostic accuracyXiaolin Chen, Xiao Pang, Yan Zhao, et al.Journal of Medicinal Chemistry|June 20, 2025
Discovery of a Potent, Selective, and Multiple His435 Mutation-Sensitive Thyroid Hormone Receptor β AgonistQiu Li, Benqiang Yao, Shiting Zhao, et al.Journal of Nanobiotechnology|July 16, 2025
CXCL12-targeting siRNA nanoparticles alleviate immunosuppression and inhibit tumor progression in esophageal squamous cell carcinomaShuyao Zhang, Hong Jiang, Chengkuan Zhao, et al.International Immunopharmacology|August 30, 2023
miR-214 could promote myocardial fibrosis and cardiac mesenchymal transition in VMC mice through regulation of the p53 or PTEN-PI3K-Akt signali pathway, promoting CF proliferation and inhibiting its ng pathwayXianggui Huang, Danling Zheng, Chong Liu, et al.International Immunopharmacology|March 5, 2024
Therapeutic potential of ADSC-EV-derived lncRNA DLEU2: A novel molecular pathway in alleviating sepsis-induced lung injury via the miR-106a-5p/LXN axisWei He, Chengcheng Xu, Yuying Huang, et al.Journal of Medicinal Chemistry|March 4, 2026
Discovery of XYD270 as a Potent, Selective, and Orally Efficacious BRD9 PROTAC for Cancer TherapyYumin Huang, Guizhen Cheng, Xin Tang, et al.Pageof 8